HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: OTC Rogaine

This article was originally published in The Rose Sheet

Executive Summary

OTC Rogaine: Will be available on store shelves in early April following FDA approval of the baldness remedy on Feb. 9. The company will offer both Rogaine for Men in blue packaging and Rogaine for Women in salmon-colored containers. Except for the packaging, the OTC formula, which includes 2% minoxidil, will be identical to prescription Rogaine. After failing to clear the proposed switch during its first review of Upjohn's application in July 1994, FDA's Nonprescription Drugs Advisory Committee recommended approval of the OTC switch at a subsequent meeting in November 1995 after seeing several new studies that tested consumer use and label comprehension ("The Rose Sheet" Nov. 27, p. 8)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel